Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Butterfly NetworkBFLY +4.14%58 Debt-to-Equity is 0.10 as of Jun. 2026, which is at its 10-year median of 0.10. GuruFocus rates BFLY with a GF Score™ of 58/100 and a GF Value™ of $2.45 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 700 Medical Devices & Instruments companies, Butterfly Network ranks better than 67.29% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Butterfly Network's Debt-to-Equity or its related term are showing as below:
BFLY'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.15 Med: 0.1 Max: 0.14
Current: 0.1
During the past 7 years, the highest Debt-to-Equity Ratio of Butterfly Network was 0.14. The lowest was -0.15. And the median was 0.10.
BFLY's Debt-to-Equity is ranked better than 67.29% of 700
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs BFLY: 0.10
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Butterfly Network Debt-to-Equity Related Terms
Butterfly Network Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Butterfly Network's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BFLY vs ALMR, UFPT, ENOV: Debt-to-Equity Comparison
For the Medical Devices subindustry, Butterfly Network's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Butterfly Network Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Butterfly Network's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Butterfly Network's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Butterfly Network (BFLY) has a Debt-to-Equity of 0.10 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Butterfly Network and its competitors. This is near median its historical median of 0.10. According to the industry distribution chart, Butterfly Network ranks #229 out of 700 companies in the Medical Devices & Instruments industry, placing it in the top 32.7%.
Is Butterfly Network's Debt-to-Equity too high?
Butterfly Network's current Debt-to-Equity of 0.10 is near median its 10-year median of 0.10. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Butterfly Network's value of 0.10 is 56.5% below this industry median. Based on the distribution chart, Butterfly Network ranks #229 out of 700 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Butterfly Network has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Butterfly Network's Debt-to-Equity compare to ALMR and UFPT?
According to the Medical Devices & Instruments industry distribution chart, Butterfly Network ranks #229 out of 700 companies for Debt-to-Equity. This puts Butterfly Network in the upper half of its industry. The industry median Debt-to-Equity is 0.23. Butterfly Network's value of 0.10 is 56.5% below this benchmark. While the company's 10-year median is 0.10 vs. the industry median of 0.23, Butterfly Network has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Butterfly Network's current Debt-to-Equity of 0.10 is 56.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Butterfly Network and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Butterfly Network's current Debt-to-Equity is 0.10, which is near median its own 10-year median of 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Butterfly Network stock overvalued right now?
Based on GuruFocus' analysis, Butterfly Network (BFLY) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.45, compared to a current price of $9.55 — trading 289.8% above its estimated fair value. The current Debt-to-Equity is 0.10, which is near median its 10-year median of 0.10 and 56.5% below the Medical Devices & Instruments industry median of 0.23. Butterfly Network's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Butterfly Network (BFLY), the current Debt-to-Equity is 0.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Butterfly Network (BFLY) Overvalued in 2026?
Based on GuruFocus' analysis, Butterfly Network stock appears to be overvalued.
The current stock price of $9.55 is trading 289.8% above its estimated GF Value™ of $2.45.
GuruFocus considers Butterfly Network to be Significantly Overvalued.
Key valuation signals for BFLY:
Debt-to-Equity: 0.10 (near median its 10-year median of 0.10)
GF Value™: $2.45 vs. price of $9.55 (289.8% above fair value)
Industry Position: 56.5% below the Medical Devices & Instruments median (#229 of 700)
No single metric tells the full story. See the BFLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
58GF Score
Get the complete analysis for BFLY
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFLY has been successfully added to your 
